drugset / Trial / NCT00003141

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors

NCT00003141

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctors to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combination chemotherapy plus peripheral stem cell transplantation in treating infants with malignant brain or spinal cord tumors.

Timeline

Start
1998-03
Primary completion
2007-12
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Thiotepa Other / unclassified Intravenous
Background Carboplatin Small molecule Intravenous
Background Cisplatin Other / unclassified Intravenous
Background Cyclophosphamide Other / unclassified Intravenous
Background Etoposide Small molecule Intravenous
Background Vincristine Small molecule Intravenous
Background filgrastim Protein / enzyme biologic Intravenous